INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
KJ
Corporate insider

Knotnerus Tim Jasper

Director, Chief Executive OfficerCIK 0002120886

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells2 / 0
Max Insider Score49
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
38
KJ
Knotnerus Tim JasperDirector, Chief Executive Officer
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$44K
5,000 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    AgomAb Therapeutics NVDirector, Chief Executive Officer · Oct 7, 2026
49
KJ
Knotnerus Tim JasperDirector, Chief Executive Officer
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY
$51K
6,000 sh
Oct 5, 2026
Oct 7, 2026
traded Oct 5, 2026
+2d
SEC FORM 4

Evidence

Data sources
SEC FORM 441m ago
HOUSE PTR41m ago
SEC 13F41m ago
ROBINHOOD CHAIN41m ago